Aminazine
Brand names,
Aminazine
Analogs
Aminazine
Brand Names Mixture
Aminazine
Chemical_Formula
C17H20N2S
Aminazine
RX_link
No information avaliable
Aminazine
fda sheet
Aminazine
msds (material safety sheet)
Aminazine
Synthesis Reference
No information avaliable
Aminazine
Molecular Weight
284.42 g/mol
Aminazine
Melting Point
< 25 oC
Aminazine
H2O Solubility
14.2 mg/L
Aminazine
State
Liquid
Aminazine
LogP
4.893
Aminazine
Dosage Forms
Tablet; Oral liquid; Injection
Aminazine
Indication
Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
Aminazine
Pharmacology
Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.
Aminazine
Absorption
Absorption may be erratic and peak plasma concentrations show large interindividual differences.
Aminazine
side effects and Toxicity
Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.
Aminazine
Patient Information
No information avaliable
Aminazine
Organisms Affected
Humans and other mammals